Patents by Inventor Bon-Hong Min

Bon-Hong Min has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis
    Patent number: 7413735
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting angiogenesis which comprises arginine deiminase as an active ingredient, where the arginine deiminase, obtained from Mycoplasma arginini or prepared by a genetic recombination technique, may be conjugated to an activated polymer to lower its immunogenecity and increase its life time. The pharmaceutical composition of the present invention exhibits an excellent inhibitory activity against angiogenesis.
    Type: Grant
    Filed: June 20, 2005
    Date of Patent: August 19, 2008
    Assignee: Angio Lab, Inc.
    Inventors: Bon-Hong Min, Myung-Ok Park, Min-Young Kim, Byung-Young Park, Boe-Gwun Chun, Sang-Wook Kang, Chang-Hee Moon
  • Pharmaceutical composition comprising arginine deiminase for inhibiting angiogenesis
    Publication number: 20060002915
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting angiogenesis which comprises arginine deiminase as an active ingredient, where the arginine deiminase, obtained from Mycoplasma arginini or prepared by a genetic recombination technique, may be conjugated to an activated polymer to lower its immunogenecity and increase its life time. The pharmaceutical composition of the present invention exhibits an excellent inhibitory activity against angiogenesis.
    Type: Application
    Filed: June 20, 2005
    Publication date: January 5, 2006
    Inventors: Bon-Hong Min, Myung-Ok Park, Min-Young Kim, Byung-Young Park, Boe-Gwun Chun, Sang-Wook Kang, Chang-Hee Moon
  • Pharmaceutical composition comprising arginine deiminasa for inhibiting angio-genesis
    Publication number: 20040096437
    Abstract: The present invention relates to a pharmaceutical composition for inhibiting angiogenesis which comprises arginine deiminase as an active ingredient, where the arginine deiminase, obtained from Mycoplasma arginini or prepared by a genetic recombination technique, may be conjugated to an activated polymer to lower its immunogenecity and increase its life time. The pharmaceutical composition of the present invention exhibits an excellent inhibitory activity against angiogenesis.
    Type: Application
    Filed: January 24, 2003
    Publication date: May 20, 2004
    Inventors: Bon-Hong Min, Myung-Ok Park, Min-Young Kim, Byung-Young Park, Boe-Gwun Chun, Sang-Wook Kang, Chang-Hee Moon